{
    "clinical_study": {
        "@rank": "1600", 
        "arm_group": [
            {
                "arm_group_label": "Lung Cancer", 
                "description": "Early-late stage primary lung cancer"
            }, 
            {
                "arm_group_label": "Lung Neoplasm", 
                "description": "Benign non-calcified pulmonary nodules"
            }
        ], 
        "biospec_descr": {
            "textblock": "Two 10ml blood samples (serum and plasma) from the patient will be analyzed for protein\n      biomarkers associated with lung cancer diagnosis"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The study goal is to collect blood samples from individuals at risk for lung cancer in order\n      to identify protein markers for diagnosis of lung cancer in the Chinese population."
        }, 
        "brief_title": "Biomarkers for Diagnosis of Lung Cancer", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Lung Cancer", 
            "Lung Neoplasm"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults \u2265 18 years of age\n\n          -  Patients referred to pulmonologists, oncologists, or thoracic surgeons for diagnosis\n             of suspicious pulmonary nodules as either lung cancer or benign and undergoing\n             bronchoscopic biopsy\n\n          -  Patients will be enrolled if the result of the bronchoscopic biopsy is a diagnosis of\n             NSCLC or benign pulmonary nodule\n\n          -  Cases: Patients with untreated non-small cell lung cancer, i.e. primary lung\n             adenocarcinoma or squamous cell carcinoma of early\n\n          -  Computed tomography or X-Ray is available and shows a suspicious pulmonary nodule\n\n          -  A biopsy or surgical resection to clarify the nature of the lung nodule is available\n             (NSCLC or benign, including histological diagnosis) in both groups\n\n          -  Controls: Patients must be available for a 6 month follow-up to confirm benign\n             diagnosis\n\n          -  A serum and plasma sample was collected prior to any treatment of the lung nodule\n             beyond biopsy\n\n          -  No other cancer diagnosis in the last 5 years excluding non-melanoma skin cancer\n\n          -  Patients must be fully informed of the investigational nature of the procedure and\n             sign an informed consent.\n\n        Exclusion Criteria:\n\n          -  Prior treatment for lung cancer by chemotherapy or surgery (excluding biopsy)\n\n          -  Patients with benign nodules who are not able or willing to have a 6-month follow-up\n             visit to confirm benign diagnosis\n\n          -  Diagnosis or treatment of other cancer in the last 5 years excluding non-melanoma\n             skin cancer. In the judgment of the clinical investigator, patients who are likely to\n             be non compliant or uncooperative during the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "A total of 300 patients will be recruited from hospital pulmonary clinics. The study\n        participants will have pulmonary nodules suspicious for lung cancer and a bronchial biopsy\n        diagnosis of NSCLC or probable benign. Approximately half of the patients will be cases\n        and half controls."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050100", 
            "org_study_id": "SKTCTCH0001"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "primary lung adenocarcinoma Stages I, II, IIA,  IIIB", 
            "squamous cell carcinoma Stages I, II, IIA, IIIB", 
            "benign non-calcified pulmonary nodules", 
            "early detection"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "location": [
            {
                "contact": {
                    "email": "bai.chunxue@zs-hospital.sh.cn", 
                    "last_name": "Chunxue Bai", 
                    "phone": "(86) 13681971807"
                }, 
                "facility": {
                    "address": {
                        "city": "Shang Hai", 
                        "country": "China"
                    }, 
                    "name": "Zhongshan Hospital Fudan University"
                }, 
                "investigator": {
                    "last_name": "Chunxue Bai", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "zhangxiaoju1010@hotmail.com", 
                    "last_name": "Xiaoju Zhang", 
                    "phone": "(86) 15837101166"
                }, 
                "facility": {
                    "address": {
                        "city": "Zheng zhou", 
                        "country": "China"
                    }, 
                    "name": "Henan province People's hospital"
                }, 
                "investigator": {
                    "last_name": "Xiaoju Zhang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "Biomarkers for Diagnosis of Lung Cancer", 
        "overall_official": [
            {
                "affiliation": "Zhongshan Hospital Fudan Universit", 
                "last_name": "Chunxue Bai", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Henan province People's hospital", 
                "last_name": "Xiaoju Zhang", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "SK Telecom will utilize 15 single-plex quantitative Polymerase Chain Reaction (qPCR) assays to analyze an initial set of 300 clinical samples in China.  SomaLogic will analyze these samples on the SOMAscan array (>1000 proteins) for additional lung cancer biomarker candidates.", 
            "measure": "Identification of blood biomarkers for detection of lung cancer", 
            "safety_issue": "No", 
            "time_frame": "6 months after enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050100"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "SK Medical (Beijing) Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "SK Medical (Beijing) Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}